会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明申请
    • Extra strength polymer composite construction material and process for making the same
    • 超强度聚合物复合材料及其制造方法
    • US20080299372A1
    • 2008-12-04
    • US11899745
    • 2007-09-08
    • Gary StidhamChristopher BrownMarvin Peplow
    • Gary StidhamChristopher BrownMarvin Peplow
    • B32B5/02B32B27/08B32B5/00B29C41/22B32B3/12
    • B32B27/40B32B27/12Y10T428/249976Y10T428/249986Y10T428/269Y10T428/31547
    • A composite material that can be economically produced without the emission of VOCs that is extremely strong and is bonded at the molecular level. An embodiment of the present invention can be a composite of two or more layers with a first layer made from an aliphatic polymer like a polyurea and a resin like an isocyanate resin. A third layer of strengthened urethane foam can optionally be used. The composite material can be made up of layers of material with a first layer of a polyurea polymer and the second layer of an isocyanate resin chemically bonded to the first layer. The first layer can have a glossy outer surface if desired. The second layer can also optionally contain carbon fibers, nano-tubes or basalt fibers for extra strength if desired. The material can be produced in sheets of from 8 to 12 feet wide and from 40 to 60 feet long. Carbon fibers, carbon nano-tubes and Basalt fibers can be added for strength and rigidity. The optional urethane foam layer can contain carbon fibers, carbon nano-tubes or basalt or other fibers for strengthening.
    • 一种复合材料,可以经济地生产而不发出非常强的VOC,并在分子水平上结合。 本发明的一个实施方案可以是两层或更多层与由诸如聚脲的脂族聚合物和异氰酸酯树脂之类的树脂制成的第一层的复合物。 可以任选地使用第三层增强的聚氨酯泡沫。 复合材料可以由具有第一层聚脲聚合物的材料层和与第一层化学键合的异氰酸酯树脂的第二层组成。 如果需要,第一层可以具有光泽的外表面。 如果需要,第二层还可以任选地含有碳纤维,纳米管或玄武岩纤维,用于额外的强度。 该材料可以生产8至12英尺宽和40至60英尺长的片材。 可以添加碳纤维,碳纳米管和玄武岩纤维的强度和刚度。 可选的聚氨酯泡沫层可以包含碳纤维,碳纳米管或玄武岩或其他用于增强的纤维。
    • 25. 发明授权
    • Recovery of a network element after a restart
    • 重新启动后恢复网元
    • US07315940B1
    • 2008-01-01
    • US10960154
    • 2004-10-07
    • Jocelyn AudetteCraig ParkerChristopher BrownDoug WongSandra Fougere
    • Jocelyn AudetteCraig ParkerChristopher BrownDoug WongSandra Fougere
    • G06F15/177G06F9/24G06F1/24
    • G06F11/1417
    • Described are a system and method for initializing a traffic card in a network element after a restart. The traffic card receives status information regarding a shelf processor card over a low-level link. If the status information indicates that the shelf processor card is unavailable, the traffic card supports traffic using provisioning data stored at the traffic card. Otherwise, if the status information indicates that the shelf processor card is un-initialized or initializing, the traffic card waits for the shelf processor card to be available. If the shelf processor is operational, the traffic card communicates with the shelf processor card to determine which provisioning data to use. When restarting the card, boot code stored in a first memory bank is executed. If this boot code is determined to be invalid, execution is redirected to boot code stored in a second memory bank to continue the restart process of the card.
    • 描述了在重新启动之后初始化网络元件中的交通卡的系统和方法。 交通卡通过低级链路接收关于货架处理器卡的状态信息。 如果状态信息指示货架处理器卡不可用,则交通卡支持使用存储在交通卡处的供应数据。 否则,如果状态信息指示货架处理器卡未初始化或初始化,则交易卡等待货架处理器卡可用。 如果货架处理器可操作,则交通卡与货架处理器卡通信以确定要使用的供应数据。 当重新启动卡时,执行存储在第一存储体中的引导代码。 如果该引导代码被确定为无效,则执行被重定向到存储在第二存储体中的引导代码,以继续重新启动卡。
    • 28. 发明申请
    • Determination of a measure of a glycation end-product or disease state using tissue fluorescence preferentially from the dermis
    • 使用优先来自真皮的组织荧光测定糖基化终产物或疾病状态的量度
    • US20060211928A1
    • 2006-09-21
    • US11417463
    • 2006-05-03
    • Edward HullMarwood EdigerChristopher BrownJohn MaynardRobert Johnson
    • Edward HullMarwood EdigerChristopher BrownJohn MaynardRobert Johnson
    • A61B5/00
    • A61B5/1455A61B5/0059A61B5/0064A61B5/0066A61B5/0068A61B5/0071A61B5/0075A61B5/14532A61B5/412A61B5/441
    • A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can comprise single wavelength excitation light, scanning of excitation light (illuminating the tissue at a plurality of wavelengths), detection at a single wavelength, scanning of detection wavelengths (detecting emitted light at a plurality of wavelengths), and combinations thereof. The invention also can comprise correction techniques that reduce determination errors due to detection of light other than that from fluorescence of a chemical in the tissue. For example, the reflectance of the tissue can lead to errors if appropriate correction is not employed. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, including a variety of methods for generating such models. Other biologic information can be used in combination with the fluorescence properties to aid in the determination of a measure of tissue state. The invention also comprises apparatuses suitable for carrying out the method, including appropriate light sources, detectors, and models (for example, implemented on computers) used to relate detected fluorescence and a measure of tissue state.
    • 确定个体中组织状态(例如,糖基化终产物或疾病状态)的量度的方法。 用激发光照射个体组织的一部分,然后检测由组织响应于激发光的化学物质的荧光而由组织发出的光。 检测到的光可以与将荧光与组织状态的测量相关联的模型组合以确定组织状态。 本发明可以包括单波长激发光,激发光的扫描(以多个波长照射组织),单个波长的检测,检测波长的扫描(检测多个波长的发射光)及其组合。 本发明还可以包括校正技术,其减少由于检测到除了组织中的化学物质的荧光以外的光的测定误差。 例如,如果不采用适当的校正,组织的反射率可能导致错误。 本发明还可以包括将荧光与组织状态的测量相关联的各种模型,包括用于产生这种模型的各种方法。 其他生物信息可与荧光性质结合使用,有助于测定组织状态。 本发明还包括适于执行该方法的装置,包括用于检测荧光和组织状态测量的适当的光源,检测器和模型(例如,在计算机上实现)。